Chen Li Meng
Chen Li Meng — Chief Physician — Nephrology — Peking Union Medical College Hospital
Specialties
Acute kidney injury, chronic nephritis, nephrotic syndrome, hereditary kidney diseases (hypokalemia, Fanconi syndrome), immune- and metabolism-related kidney diseases (hypertension, hyperuricemia, diabetes, systemic vasculitis, renal damage from Sjögren's syndrome), kidney replacement therapy (automated peritoneal dialysis, specialized blood purification)
Education
Graduated from West China School of Medicine, Clinical Medicine major (1994), Peking Union Medical College (PhD, 1997-2001), NIH-NIDDK Postdoctoral Fellow (2004-2006)
Professional Experience
With 30 years of medical practice, specializing in the diagnosis and treatment of common, difficult, rare, and critical kidney diseases, conducting genetic and immune-related kidney disease research, and renal tubular interstitial diseases: hypertension, hyperuricemia, salt-wasting nephropathy, and parathyroid bone metabolism diseases, with clinical, basic, and translational research. Actively participating in and leading the construction of multiple national rare disease platforms, leading a team to explore applications in kidney molecular pathology, artificial intelligence, and teleinformatics in medicine.
Professional Roles
Serving as Cuhk Scholar Distinguished Professor, Associate Editor of the Journal of the American Society of Nephrology (JASN) (2017-2023), Vice President of the Chinese Geriatrics Society, President of the Nephrology Branch, Member of the Expert Committee on Rare Disease Diagnosis and Treatment and Assurance of the National Health Commission, Deputy Director of the National Rare Disease Quality Control Center, Standing Committee Member of the Rare Disease Branch of the Chinese Medical Association, Deputy Director of the Parathyroid and Bone Metabolism Branch of the Chinese Research Hospital Association, Deputy Director of the Nephrology Branch of the Beijing Medical Association, and Incoming Chair of the Rare Disease Branch of the Beijing Medical Association.